WO2011039757A3 - Compositions and methods for prognosis of renal cancer - Google Patents
Compositions and methods for prognosis of renal cancer Download PDFInfo
- Publication number
- WO2011039757A3 WO2011039757A3 PCT/IL2010/000806 IL2010000806W WO2011039757A3 WO 2011039757 A3 WO2011039757 A3 WO 2011039757A3 IL 2010000806 W IL2010000806 W IL 2010000806W WO 2011039757 A3 WO2011039757 A3 WO 2011039757A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- prognosis
- renal cancer
- compositions
- methods
- nucleic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Described herein are compositions and methods for the prognosis of renal cancer patients after surgical operation. Specifically the invention relates to microRNA molecules associated with the prognosis of renal cancer, as well as various nucleic acid molecules relating thereto or derived therefrom.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24845809P | 2009-10-04 | 2009-10-04 | |
US61/248,458 | 2009-10-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2011039757A2 WO2011039757A2 (en) | 2011-04-07 |
WO2011039757A3 true WO2011039757A3 (en) | 2011-12-29 |
Family
ID=43826732
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IL2010/000806 WO2011039757A2 (en) | 2009-10-04 | 2010-10-04 | Compositions and methods for prognosis of renal cancer |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2011039757A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2744910B1 (en) * | 2011-08-19 | 2016-09-14 | Hummingbird Diagnostics GmbH | Complex sets of mirnas as non-invasive biomarkers for kidney cancer |
EP2702998A1 (en) * | 2012-08-31 | 2014-03-05 | IMBA-Institut für Molekulare Biotechnologie GmbH | Therapeutic and diagnostic miRNA regulator in kidney disease |
ES2606790B1 (en) * | 2015-09-23 | 2018-01-17 | Fundación Para La Investigación Biomédica Del Hospital 12 De Octubre | Prognostic method to identify risk of recurrence in patients with kidney cancer type clear cell renal carcinoma stages I and II and kit |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009036236A1 (en) * | 2007-09-14 | 2009-03-19 | The Ohio State University Research Foundation | Mirna expression in human peripheral blood microvesicles and uses thereof |
-
2010
- 2010-10-04 WO PCT/IL2010/000806 patent/WO2011039757A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009036236A1 (en) * | 2007-09-14 | 2009-03-19 | The Ohio State University Research Foundation | Mirna expression in human peripheral blood microvesicles and uses thereof |
Non-Patent Citations (3)
Title |
---|
GOTTARDO ET AL.: "Micro-RNA profiling in kidney and bladder cancers.", UROL ONCOL, vol. 25, no. 5, 2007, pages 387 - 392, XP022262807, DOI: doi:10.1016/j.urolonc.2007.01.019 * |
JUAN ET AL.: "Identification of a microRNA panel for clear-cell kidney cancer.", UROLOGY, vol. 75, no. 4, 29 December 2009 (2009-12-29), pages 835 - 841, XP026990724 * |
JUNG ET AL.: "MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy.", J CELL MOL MED., vol. 13, no. 9B, September 2009 (2009-09-01), pages 3918 - 3928, XP008154297, DOI: doi:10.1111/j.1582-4934.2009.00705.x * |
Also Published As
Publication number | Publication date |
---|---|
WO2011039757A2 (en) | 2011-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010018563A3 (en) | Compositions and methods for the prognosis of lymphoma | |
WO2009111643A3 (en) | Microrna markers for recurrence of colorectal cancer | |
WO2014028429A3 (en) | Enzymes and polymerases for the synthesis of rna | |
WO2010099161A8 (en) | Micrornas in never-smokers and related materials and methods | |
AU2016204376A1 (en) | MicroRNA-based methods and compositions for the diagnosis and treatment of ovarian cancer | |
WO2012083969A3 (en) | Microrna for diagnosis of pancreatic cancer | |
WO2012088290A3 (en) | Tri-variable domain binding proteins and uses thereof | |
WO2009108860A3 (en) | Microrna-based methods and compositions for the diagnosis, pronosis and treatment of prostate related disorders | |
WO2008036765A3 (en) | Micrornas differentially expressed in pancreatic diseases and uses thereof | |
WO2012174256A3 (en) | Dna methylation profiles in cancer | |
WO2012068400A3 (en) | Mirnas as biomarkers for distinguishing benign from malignant thyroid neoplasms | |
WO2009108856A3 (en) | Microrna signatures associated with human chronic lymphocytic leukemia (ccl) and uses thereof | |
WO2012068383A3 (en) | ncRNA AND USES THEREOF | |
WO2009129246A3 (en) | Compositions and methods for preparing and using same | |
WO2011106541A3 (en) | Diagnostic methods involving loss of heterozygosity | |
WO2011021177A3 (en) | Compositions and methods for prognosis and treatment of prostate cancer | |
WO2013040251A3 (en) | Methods and compositions involving mir-135b for distinguishing pancreatic cancer from benign pancreatic disease | |
WO2009153774A3 (en) | Compositions and methods for prognosis of ovarian cancer | |
WO2012024282A3 (en) | 1,5-diphenyl-penta-1,4-dien-3-one compounds | |
WO2009120712A3 (en) | Compositions and methods for diagnosing and treating melanoma | |
WO2009071082A3 (en) | Rna antagonist compounds for the modulation of pik3ca expression | |
WO2011130426A3 (en) | Compositions and methods for treatment of melanoma | |
WO2010101793A3 (en) | Methods and compositions for the diagnosis, prognosis and treatment of cancer | |
WO2011044458A8 (en) | Compositions and methods for diagnosing genome related diseases and disorders | |
WO2009147658A3 (en) | Compositions and methods for diagnosis, prognosis and treatment of mesothelioma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10820011 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 10820011 Country of ref document: EP Kind code of ref document: A2 |